JLL vs MDGL · P/E 23, rev $13.31B vs rev $675.6M
Jones Lang LaSalle Incorporated (JLL) versus Madrigal Pharmaceuticals Inc (MDGL) — a side-by-side from cached financials, not a winner call.
Jones Lang LaSalle Incorporated (JLL) is a real estate services company listed on US.
Madrigal Pharmaceuticals Inc (MDGL) is a biotechnology company listed on NASDAQ.
Latest reported JLL revenue for 2026-06-30 was $13.31B. Net income was $373.7M. JLL currently screens at market cap $12.12B and trailing P/E 23.0.
Latest reported MDGL revenue for 2026-06-30 was $675.6M. Net income was -$152.3M. MDGL currently screens at market cap $11.56B.
JLL currently screens at market cap $12.12B and trailing P/E 23.0. MDGL currently screens at market cap $11.56B.
Not investment advice. Open the JLL and MDGL stock pages for the full models.
Not investment advice.